Ligand Pharmaceuticals
LGND
#4395
Rank
€1.73 B
Marketcap
94,76 €
Share price
1.28%
Change (1 day)
60.71%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): 1,43 €

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 1,42 €. In 2022 the company made an earnings per share (EPS) of -1,79 € a decrease over its 2021 EPS that were of 3,12 €.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)1,43 €-180.29%
2022-1,79 €-157.23%
20213,12 €-2571.43%
2020-0,13 €-100.46%
201927,62 €353.48%
20186,09 €1025%
20170,54 €-700%
2016-0,09024 €-100.87%
201510,43 €1859.32%
20140,53 €5.36%
20130,51 €8.0704505322479E+18%
20120,0000000000 €-100%
20110,44 €-194.23%
2010-0,47 €548.38%
2009-0,07237 €-98.7%
2008-5,58 €-136.52%
200715,27 €-787.8%
2006-2,22 €-14.58%
2005-2,60 €-21.31%
2004-3,30 €-55.15%
2003-7,36 €81.33%
2002-4,06 €2.74%
2001-3,95 €-45.93%
2000-7,31 €-8.5%
1999-7,99 €-45.52%
1998-14,66 €-3.97%
1997-15,27 €132.31%
1996-6,57 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
12,77 € 801.27%🇺🇸 USA
-0,32 €-122.93%🇺🇸 USA
3,16 € 122.98%🇬🇧 UK
1,64 € 16.03%🇺🇸 USA
1,68 € 18.47%🇺🇸 USA
4,90 € 245.81%🇺🇸 USA
3,58 € 152.87%🇺🇸 USA
4,62 € 226.11%🇺🇸 USA
12,71 € 797.15%🇺🇸 USA